Gulf News

9.35 billion dirhams, the proceeds of conference and exhibition deals "DUVAT 2025"

DUBAI, 9 JANUARY / WAM / The total value of deals at the “DUPHAT 2025” conference and exhibition at its conclusion today reached 9.35 billion dirhams, which strengthens the UAE’s position in the pharmaceutical market, supports the objectives of the National Drug Policy, and achieves a pivotal role in achieving the objectives of the National Drug Policy, which aims to increase The value of the pharmaceutical market increased by between 10% and 15% within five years of its launch.

“DUPHAT 2025” is a platform that brings together international and local companies to enhance innovation and business opportunities. It attracted more than 31,000 visitors from 101 countries, with the participation of 1,400 international companies at the Dubai World Trade Center, where it showcased the latest innovations in pharmaceuticals and healthcare in addition to 155 speakers in 130 sessions. 9 workshops and 400 scientific posters from university students.

Participants obtained 83.5 accredited academic hours. The event also witnessed the launch of the “Vita Show Dubai” to promote innovation in nutritional supplements, with the participation of 275 brands, which reflects the growth of the supplements market.

Ambassador Dr. Abdul Salam Al Madani, CEO of DUPHAT, stressed the importance of supporting the pharmaceutical sector through scientific research and international partnerships, noting the commitment to supporting scientific research and development through the launch of “Vita Show Dubai.”

He explained that the deals achieved during DUPHAT demonstrate the growth of the pharmacy and technology industry in the UAE and confirm its leadership role in promoting health innovation globally.

The exhibition highlighted international entries from Poland, China and Turkey, highlighting innovations and promoting trade and cultural cooperation as companies presented innovative solutions and technologies, such as vaccination programs in pharmacies.

GSK has focused on innovation to enhance public health and according to its Vice President, Boyud Chungvisal, their participation in DUPHAT is a strategic opportunity to collaborate and exchange ideas with health leaders.

He pointed out that the partnership with the Dubai Health Authority aims to provide pharmacists with the latest tools to improve patient care and achieve better health outcomes.

The DUPHAT 2025 Conference and Exhibition, organized by INDEX, is a prominent international event with the support of the Dubai Health Authority and the participation of leading global pharmaceutical institutions.

Related Articles

Back to top button